Copyright Reports & Markets. All rights reserved.

Global On-body Drug Delivery Devices Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global On-body Drug Delivery Devices Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for On-body Drug Delivery Devices by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for On-body Drug Delivery Devices by Country/Region, 2017, 2022 & 2028
  • 2.2 On-body Drug Delivery Devices Segment by Type
    • 2.2.1 Syringe
    • 2.2.2 Infusion Pump
    • 2.2.3 Other
  • 2.3 On-body Drug Delivery Devices Sales by Type
    • 2.3.1 Global On-body Drug Delivery Devices Sales Market Share by Type (2017-2022)
    • 2.3.2 Global On-body Drug Delivery Devices Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global On-body Drug Delivery Devices Sale Price by Type (2017-2022)
  • 2.4 On-body Drug Delivery Devices Segment by Application
    • 2.4.1 Cancer
    • 2.4.2 Diabetes
    • 2.4.3 Auto-immune Disease
    • 2.4.4 Others
  • 2.5 On-body Drug Delivery Devices Sales by Application
    • 2.5.1 Global On-body Drug Delivery Devices Sale Market Share by Application (2017-2022)
    • 2.5.2 Global On-body Drug Delivery Devices Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global On-body Drug Delivery Devices Sale Price by Application (2017-2022)

3 Global On-body Drug Delivery Devices by Company

  • 3.1 Global On-body Drug Delivery Devices Breakdown Data by Company
    • 3.1.1 Global On-body Drug Delivery Devices Annual Sales by Company (2020-2022)
    • 3.1.2 Global On-body Drug Delivery Devices Sales Market Share by Company (2020-2022)
  • 3.2 Global On-body Drug Delivery Devices Annual Revenue by Company (2020-2022)
    • 3.2.1 Global On-body Drug Delivery Devices Revenue by Company (2020-2022)
    • 3.2.2 Global On-body Drug Delivery Devices Revenue Market Share by Company (2020-2022)
  • 3.3 Global On-body Drug Delivery Devices Sale Price by Company
  • 3.4 Key Manufacturers On-body Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers On-body Drug Delivery Devices Product Location Distribution
    • 3.4.2 Players On-body Drug Delivery Devices Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for On-body Drug Delivery Devices by Geographic Region

  • 4.1 World Historic On-body Drug Delivery Devices Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global On-body Drug Delivery Devices Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global On-body Drug Delivery Devices Annual Revenue by Geographic Region
  • 4.2 World Historic On-body Drug Delivery Devices Market Size by Country/Region (2017-2022)
    • 4.2.1 Global On-body Drug Delivery Devices Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global On-body Drug Delivery Devices Annual Revenue by Country/Region
  • 4.3 Americas On-body Drug Delivery Devices Sales Growth
  • 4.4 APAC On-body Drug Delivery Devices Sales Growth
  • 4.5 Europe On-body Drug Delivery Devices Sales Growth
  • 4.6 Middle East & Africa On-body Drug Delivery Devices Sales Growth

5 Americas

  • 5.1 Americas On-body Drug Delivery Devices Sales by Country
    • 5.1.1 Americas On-body Drug Delivery Devices Sales by Country (2017-2022)
    • 5.1.2 Americas On-body Drug Delivery Devices Revenue by Country (2017-2022)
  • 5.2 Americas On-body Drug Delivery Devices Sales by Type
  • 5.3 Americas On-body Drug Delivery Devices Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC On-body Drug Delivery Devices Sales by Region
    • 6.1.1 APAC On-body Drug Delivery Devices Sales by Region (2017-2022)
    • 6.1.2 APAC On-body Drug Delivery Devices Revenue by Region (2017-2022)
  • 6.2 APAC On-body Drug Delivery Devices Sales by Type
  • 6.3 APAC On-body Drug Delivery Devices Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe On-body Drug Delivery Devices by Country
    • 7.1.1 Europe On-body Drug Delivery Devices Sales by Country (2017-2022)
    • 7.1.2 Europe On-body Drug Delivery Devices Revenue by Country (2017-2022)
  • 7.2 Europe On-body Drug Delivery Devices Sales by Type
  • 7.3 Europe On-body Drug Delivery Devices Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa On-body Drug Delivery Devices by Country
    • 8.1.1 Middle East & Africa On-body Drug Delivery Devices Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa On-body Drug Delivery Devices Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa On-body Drug Delivery Devices Sales by Type
  • 8.3 Middle East & Africa On-body Drug Delivery Devices Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of On-body Drug Delivery Devices
  • 10.3 Manufacturing Process Analysis of On-body Drug Delivery Devices
  • 10.4 Industry Chain Structure of On-body Drug Delivery Devices

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 On-body Drug Delivery Devices Distributors
  • 11.3 On-body Drug Delivery Devices Customer

12 World Forecast Review for On-body Drug Delivery Devices by Geographic Region

  • 12.1 Global On-body Drug Delivery Devices Market Size Forecast by Region
    • 12.1.1 Global On-body Drug Delivery Devices Forecast by Region (2023-2028)
    • 12.1.2 Global On-body Drug Delivery Devices Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global On-body Drug Delivery Devices Forecast by Type
  • 12.7 Global On-body Drug Delivery Devices Forecast by Application

13 Key Players Analysis

  • 13.1 Gerresheimer AG
    • 13.1.1 Gerresheimer AG Company Information
    • 13.1.2 Gerresheimer AG On-body Drug Delivery Devices Product Offered
    • 13.1.3 Gerresheimer AG On-body Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Gerresheimer AG Main Business Overview
    • 13.1.5 Gerresheimer AG Latest Developments
  • 13.2 Enable Injections
    • 13.2.1 Enable Injections Company Information
    • 13.2.2 Enable Injections On-body Drug Delivery Devices Product Offered
    • 13.2.3 Enable Injections On-body Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Enable Injections Main Business Overview
    • 13.2.5 Enable Injections Latest Developments
  • 13.3 NOVO Engineering
    • 13.3.1 NOVO Engineering Company Information
    • 13.3.2 NOVO Engineering On-body Drug Delivery Devices Product Offered
    • 13.3.3 NOVO Engineering On-body Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 NOVO Engineering Main Business Overview
    • 13.3.5 NOVO Engineering Latest Developments
  • 13.4 Elcam Medical
    • 13.4.1 Elcam Medical Company Information
    • 13.4.2 Elcam Medical On-body Drug Delivery Devices Product Offered
    • 13.4.3 Elcam Medical On-body Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Elcam Medical Main Business Overview
    • 13.4.5 Elcam Medical Latest Developments
  • 13.5 Battelle
    • 13.5.1 Battelle Company Information
    • 13.5.2 Battelle On-body Drug Delivery Devices Product Offered
    • 13.5.3 Battelle On-body Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Battelle Main Business Overview
    • 13.5.5 Battelle Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of On-body Drug Delivery Devices will have significant change from previous year. According to our (LP Information) latest study, the global On-body Drug Delivery Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global On-body Drug Delivery Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States On-body Drug Delivery Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global On-body Drug Delivery Devices market, reaching US$ million by the year 2028. As for the Europe On-body Drug Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main On-body Drug Delivery Devices players cover Gerresheimer AG, Enable Injections, NOVO Engineering, and Elcam Medical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of On-body Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Syringe
Infusion Pump
Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cancer
Diabetes
Auto-immune Disease
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Gerresheimer AG
Enable Injections
NOVO Engineering
Elcam Medical
Battelle
Buy now